期刊文献+

聚(乳酸-羟基乙酸)共聚物涂层的释药性能 被引量:2

Drug Release Properties of Poly(lactic-co-glycolic acid) Coatings
下载PDF
导出
摘要 以乙酸乙酯为溶剂,配制聚(乳酸-羟基乙酸)共聚物(PLGA)雷帕霉素溶液,利用滴涂法在316L不锈钢表面制备PLGA载药涂层。于37℃磷酸盐缓冲液(PBS)中进行体外动态药物释放,并用紫外-可见分光光度计测定药物释放量。结果表明:PLGA涂层中PLGA分子量越小,羟基乙酸(GA)含量越高,药物释放越快;药物释放量与滴涂量呈线性关系,药物释放率与滴涂量的倒数呈线性关系;涂层中药物含量增加,其释放量也随之增加,而药物释放率先增加后降低。 Poly(lactic-co-glycolic acid) (PLGA) rapamycin (Rap) solutions were prepared using ethyl acetate as solvent, and then PLGA coatings loading Rap were prepared through drop-coating method on the surface of 316L stainless in a shaking bath. The Rap release kinetics of PLGA coatings was studied in phosphate buffer solution (PBS) at 37 ℃ while oscillating. The mass of Rap released was measured by ultraviolet and visible spectrophotometer. Results showed that a smaller molecular weight of PLGA and a higher ratio of glycolic acid (GA) in PLGA led to a higher release rate of Rap from the coating. Rap release mass depended linearly on the volume of drop-coating solution, and the relationship between Rap release ratio and reciprocal of the volume of drop-coating solution also showed linear. With the increasing of Rap loading, Rap release mass increased non-linearly, however Rap release ratio initially increased and then decreased.
出处 《功能高分子学报》 CAS CSCD 北大核心 2014年第2期219-223,共5页 Journal of Functional Polymers
基金 国家高技术研究发展计划(863)项目(2011AA030103)
关键词 聚(乳酸-羟基乙酸)共聚物 雷帕霉素 滴涂 药物含量 药物释放 PLGA rapamycin drop-coating drug loading drug release
  • 相关文献

参考文献18

  • 1Sigwart U, Puel J, Mirkovitch V, et al. Intravascular stents to prevent occlusion and restenosis after transluminal angioplasty[J]. New England Journal of Medicine, 1987, 316(12) : 701-706.
  • 2Mintz G S, Popma J J, Pichard A D,et al. Arterial remodeling after coronary angioplasty a serial intravascular ultra- sound study[J-]. Circulation, 1996, 94(1): 35-43.
  • 3Martin D M, Boyle F J. Drug-eluting stents for coronary artery disease: A review[J]. Medical Engineering and Phy- sics, 2011, 33(2): 148-163.
  • 4Wessely R, Kastrati A, Mehilli J, et al. Randomized trial of rapamycin- and paclitaxel-eluting stents with identical bio- degradable polymeric coating and design[J]. European Heart Journal, 2007, 28(22) :2720-2725.
  • 5Acharya G, Park K. Mechanisms of controlled drug release from drug-eluting stents[J]. Advanced Drug Delivery Reviews, 2006, 58(3): 387-401.
  • 6Ruygrok P N, Muller D W, Serruys P W. Rapamycin in cardiovascular medicine[J]. Internal Medicine Journal, 2003, 33(3) : 103-109.
  • 7崔红星,张倩.聚乳酸类可吸收手术缝合线的研究进展[J].合成纤维,2004,33(4):15-16. 被引量:20
  • 8Fredenberg S, Wahlgren M, Reslow M, et al. The mechanisms of drug release in poly (lactic-co-glycolic acid)-based drug delivery systems: A review[J]. International Journal of Pharmaceutics, 2011, 415(1) : 34-52.
  • 9高惠敏,程树军.聚乳酸骨固定材料的研究[J].功能高分子学报,2004,17(2):281-284. 被引量:3
  • 10罗丙红,全大萍,廖凯荣,卢泽俭,陈用烈,高成杰,余斌.低热-高压法制备PLGA多孔支架及其体外降解研究[J].功能高分子学报,2003,16(2):149-154. 被引量:13

二级参考文献30

  • 1俞耀庭 张兴栋编.生物医用材科[M].天津:天津大学出版社,2000,12..
  • 2Dietmar W H. Scaffolds in tissue engineering bone and cartilage[J]. Biomaterials, 2000, 21:2529-- 2543.
  • 3Mooney D J, Mazzoni C L, Breuer C, et al. Stabilized polyglycolic acid fiber-based tubes for tissue engineering[J]. Biomaterials,1996,17:115--124.
  • 4Ishaug-Riley S L, Crane-Kruger G M, Yaszemski M J, et al. Three-dimensional culture of rat calvarial osteoblasts in porous biodegradable polymers[J]. Biomaterials, 1998,19 : 1405 -- 1412.
  • 5Nam Y S, Park T G. Biodegradable polymeric microcellular foams by modified thermally induced phase separation methods[J].Biomaterials, 1999,20 : 1783-- 1790.
  • 6Giodano R A, Wu B M, Borland S W, et al. Mechanical properties of dense polylactic acid structures fabricated by three dimensional printing[J]. J Biomater Sci Polym Ed, 1996,8: 63-- 75.
  • 7Nam Y S, Yoon J J, Park T G. A novel fabrication method of macroporous biodegradable polymer scaffolds using gas foaming salt as a porogen additive[J]. J Biomed Mater Res(Appl Biomat), 2000, 53:1--7.
  • 8Sheridan M H, Shea L D, Peters M C, et al. Biodegradable polymer scaffolds for tissue engineering capable of sustained growth factor delivery[J]. J Controll Rel, 2000,64 : 91 -- 102.
  • 9Lu Lichun, Peter S J, Mikos A G, et al. In vitro and in vivo dogradation of porous poly( dl-lactic-co-glycolic acid) foams[J]. Biomaterials, 2000, 21: 1837--1845.
  • 10Qing Cai, Guixin Shi, Jianzhong Bei, et al. Enzymatic degradation behavior and mechanism of poly(lactide-co-glycolide) foams by trypsin[J]. Biomaterials 2003, 24: 629--638.

共引文献38

同被引文献9

引证文献2

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部